Catriona S Bradshaw Selected Research

Pristinamycin

1/2020	Doxycycline and Sitafloxacin Combination Therapy for Treating Highly Resistant Mycoplasma genitalium.
1/2018	Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection.
1/2018	Clinical Characteristics of Anorectal Mycoplasma genitalium Infection and Microbial Cure in Men Who Have Sex With Men.
1/2017	New Horizons in Mycoplasma genitalium Treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catriona S Bradshaw Research Topics

Disease

26	Infections 09/2022 - 07/2006
12	Bacterial Vaginosis 10/2021 - 06/2006
9	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2022 - 06/2011
9	Gonorrhea 01/2022 - 02/2015
7	Reinfection 01/2019 - 01/2008
5	Urethritis 01/2019 - 07/2006
3	Papillomavirus Infections 09/2021 - 01/2015
3	Chlamydia Infections 01/2021 - 01/2017
3	Condylomata Acuminata (Genital Wart) 01/2019 - 05/2015
2	Nausea 01/2021 - 01/2019
2	Hepatitis A (Hepatitis, Infectious) 01/2020 - 01/2020
2	Proctitis 01/2019 - 01/2018
2	Syphilis 01/2017 - 01/2013
1	Pruritus (Itching) 09/2021
1	Vomiting 01/2021
1	Dysbiosis 01/2021
1	Diarrhea 01/2021
1	primary Syphilis 11/2020
1	Vaginal Discharge 01/2020
1	Suppuration 01/2020
1	Uterine Cervicitis (Cervicitis) 01/2019
1	Warts (Wart) 01/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2017
1	HIV Infections (HIV Infection) 01/2016
1	Hepatitis B 02/2014
1	Hepatitis 02/2011
1	Persistent Infection 01/2008

Drug/Important Bio-Agent (IBA)

11	Azithromycin (Zithromax)FDA LinkGeneric 01/2021 - 07/2006
10	MacrolidesIBA 09/2022 - 12/2008
9	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 02/2015
8	Moxifloxacin (Avelox)FDA Link 09/2022 - 07/2006
7	Doxycycline (Periostat)FDA LinkGeneric 01/2022 - 01/2008
4	PristinamycinIBA 01/2020 - 01/2017
3	FluoroquinolonesIBA 01/2022 - 01/2017
3	sitafloxacinIBA 12/2020 - 01/2019
3	Nucleic AcidsIBA 01/2020 - 02/2015
3	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 01/2015
3	Contraceptive Agents (Contraceptives)IBA 07/2015 - 01/2013
2	16S Ribosomal RNAIBA 01/2022 - 10/2021
2	Combined VaccinesIBA 10/2021 - 01/2015
2	Amino Acids FDA Link 09/2021 - 01/2020
2	LubricantsIBA 01/2018 - 10/2016
2	ORALIT (ORS)IBA 01/2018 - 05/2015
2	Bacterial DNAIBA 11/2017 - 10/2016
2	Pharmaceutical PreparationsIBA 01/2017 - 01/2016
2	Metronidazole (Metric)FDA LinkGeneric 01/2012 - 06/2006
1	MouthwashesIBA 01/2022
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2022
1	Imiquimod (Aldara)FDA LinkGeneric 09/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	ElementsIBA 10/2020
1	Green OrIBA 01/2020
1	VaccinesIBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	solithromycinIBA 01/2019
1	Combined Oral ContraceptivesIBA 01/2019
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2019
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2019
1	Messenger RNA (mRNA)IBA 11/2018
1	RNA (Ribonucleic Acid)IBA 11/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Biological ProductsIBA 01/2017
1	AntibodiesIBA 01/2016
1	Surface Antigens (Surface Antigen)IBA 02/2014
1	Ribosomal RNAIBA 01/2013
1	Clindamycin (Cleocin)FDA LinkGeneric 01/2012
1	CholesterolIBA 06/2011
1	Blood Glucose (Blood Sugar)IBA 06/2011
1	Transaminases (Aminotransferases)IBA 02/2011

Therapy/Procedure

10	Therapeutics 01/2021 - 06/2006
5	Condoms (Condom) 01/2022 - 02/2014
5	Aftercare (After-Treatment) 01/2018 - 06/2006
2	Hormonal Contraception 01/2019 - 01/2013
1	Ambulatory Care (Outpatient Care) 01/2013